OpenVSafe by OpenVAERS
Search V-safe

G4C-99869-14668

5 vaccinations 4 coded responses 28 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
229 / VA
Registered
2021-04-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-16
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-19
    Registered in v-safe
  3. 2021-04-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Itching · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-23
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-05-07
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-05-11
    Dose 2 — Pfizer-BioNTech
  9. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-05-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-05-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-05-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-05-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-05-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-06-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-06-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-08-10
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  19. 2021-11-11
    Survey response — 6 months, dose 2
    MedDRA: Type 1 diabetes mellitus — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Type 1 Diabetes
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-12-29
    Dose 3 — Pfizer-BioNTech
  21. 2022-05-11
    Survey response — 12 months, dose 2
    MedDRA: Lyme disease, Office visit, Pre-existing disease, Type 1 diabetes mellitus — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Ongoing Lyme disease, recently diagnosed with Type 1 diabetes which does not run in my family at all. I was a very healthy & high functioning adult until I was bit by a black legged deer tick in Jan 2020 & doctor's didn't test me until Dec 2020. · Healthcare visit (other): Visits with my GP, an Infectious Disease Specialist, multiple visits to a Neurologist, now an Endocrinologist and today had an MRI (these are mainly all at the same hospital ((b)(6) in (b)(6))
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-05-11
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  23. 2022-05-12
    Dose 4 — Pfizer-BioNTech
  24. 2022-05-12
  25. 2022-09-25
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  26. 2022-09-27
    Survey response — days 1–6 daily, dose 5
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: All likely due to my Lyme disease
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-09-28
    Survey response — days 1–6 daily, dose 5
    MedDRA: Lyme disease, Type 1 diabetes mellitus — Feeling: Good · Joint pains, Muscle or body aches · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Lyme disease, type 1 diabetes
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-09-29
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  29. 2022-10-03
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  30. 2022-10-09
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  31. 2022-10-16
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  32. 2022-10-24
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  33. 2022-10-30
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  34. 2022-11-06
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  35. 2022-12-27
    Health check-in — 3 months, dose 5
    Feeling: Fair
    Adult check-in
  36. 2023-03-26
    Health check-in — 6 months, dose 5
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-16Pfizer-BioNTech
22021-05-11Pfizer-BioNTech
32021-12-29Pfizer-BioNTech No
42022-05-12Pfizer-BioNTech No
52022-09-25Pfizer-BioNTech Flu

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — 6 months, dose 2

2021-11-11

Symptoms: Type 1 Diabetes

Release 11 — 12 months, dose 2

2022-05-11

Symptoms: Ongoing Lyme disease, recently diagnosed with Type 1 diabetes which does not run in my family at all. I was a very healthy & high functioning adult until I was bit by a black legged deer tick in Jan 2020 & doctor's didn't test me until Dec 2020.
Healthcare visit (other): Visits with my GP, an Infectious Disease Specialist, multiple visits to a Neurologist, now an Endocrinologist and today had an MRI (these are mainly all at the same hospital ((b)(6) in (b)(6))
redacted (b)(6)

Release 12 — days 1–6 daily, dose 5

2022-09-27

Systemic reaction (other): All likely due to my Lyme disease

2022-09-28

Systemic reaction (other): Lyme disease, type 1 diabetes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDLyme disease · · ✓
SDPre-existing disease · · ✓
SDType 1 diabetes mellitus · · ✓
SROCondition aggravated · · ✓
SROLyme disease · · ✓
SROPre-existing disease · · ✓
SROType 1 diabetes mellitus · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release